|
ZMPSTE24 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.64999999721738E-09 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.67679999885095E-08 |
| Normal-vs-Stage2 |
7.817100E-04 |
| Normal-vs-Stage3 |
1.54640000027406E-07 |
| Normal-vs-Stage4 |
2.80430001442511E-09 |
| Stage1-vs-Stage2 |
4.390600E-01 |
| Stage1-vs-Stage3 |
2.970400E-01 |
| Stage1-vs-Stage4 |
1.756090E-02 |
| Stage2-vs-Stage3 |
2.026200E-01 |
| Stage2-vs-Stage4 |
1.996130E-02 |
| Stage3-vs-Stage4 |
1.962230E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.45909995197258E-09 |
| Normal-vs-AfricanAmerican |
2.478200E-03 |
| Normal-vs-Asian |
5.7744000003801E-07 |
| Caucasian-vs-AfricanAmerican |
4.893600E-01 |
| Caucasian-vs-Asian |
8.021000E-01 |
| AfricanAmerican-vs-Asian |
4.164200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.47790002247694E-09 |
| Normal-vs-Female |
2.58510000072931E-08 |
| Male-vs-Female |
2.075800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.30380000421482E-08 |
| Normal-vs-Age(41-60Yrs) |
6.74390000510172E-08 |
| Normal-vs-Age(61-80Yrs) |
8.2899999975794E-08 |
| Normal-vs-Age(81-100Yrs) |
4.824200E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.290200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.904200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.743600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.034600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.734400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.079600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.956200E-02 |
| Classical-VS-Follicular |
2.711200E-01 |
| Classical-VS-Other |
2.388000E-01 |
| Classical-VS-Normal |
1.84899999755572E-08 |
| Tall-VS-Follicular |
5.821300E-03 |
| Tall-VS-Other |
9.493200E-01 |
| Tall-VS-Normal |
8.71180000361349E-08 |
| Follicular-VS-Other |
1.832180E-01 |
| Follicular-VS-Normal |
5.354500E-04 |
| Other-VS-Normal |
2.075600E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.31780000046345E-07 |
| Normal-vs-N1 |
6.07449979206365E-10 |
| N0-vs-N1 |
1.597800E-02 |
|
|
